Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd.(Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd.
Guangzhou Boji Medical Biotechnological co.,Ltd. (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
"One-stop" services for drug development include new drug project research and activity screening, pharmaceutical research (including pilot production), pharmacology and toxicology research, production of clinical drugs and agent simulatant, clinical trials, clinical data management and statistical analysis, post-market evaluation.
Guangzhou Boji Medical Biotechnological co.,Ltd
Guangzhou Boji Medical Biotechnological co.,Ltd (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Guangzhou Boji Medical Biotechnological co.,Ltd
Guangzhou Boji Medical Biotechnological co.,Ltd (Boji for short, stock code: 300404), founded in 2002 and listed in Shenzhen GEM in 2015.
Profile
Profile

Guangzhou Boji Medical Biotechnological Co., Ltd (Boji for short) was founded in 1998 andrestructured in 2002. The current registered capital is more than 10 million dollars. Boji is the earliest registered and the most experiential CRO in China. Boji is a high-tech enterprise that provides full services including regulatory affairs, preclinical research, clinical trials for phase I~IV, PMS, clinical trial for medical devices, data management and biostatistics, SMO etc.


With development for more than 10 years, Boji now has 6 subsidiaries, 25 local offices in China and several overseas offices. Boji occupies the leading position of Chinese CRO industry in its achievements, professional standards, company size and revenue.

Since foundation, Boji has provided thousands of professional services in different R&D processes for more than 500 customers:

1.More than 650 clinical trials (phaseI-V, PMS and medical devices)

2.More than 500 pre-clinical studies (efficacy, PK/PD, toxicology, CMC research)


Boji has helped its clients get:

1.More than 30 clinical trial authorizations (CTA)

2.More than 60 new drug certificates

3.More than 100 drug manufacturing certificates

  • Phone:400-0020-628
  • Address:7th Floor, Building A, Vanke Cloud Plaza, 1933 Huaguan Road, Tianhe District, Guangzhou
Copyright © Boji Medical Technology Co., Ltd. All Rights Reserved 粤ICP备13039920号 (粤)—非经营性—2020-0084 Powered by vancheer
Copyright © Boji Medical Technology Co., Ltd. All Rights Reserved 粤ICP备13039920号 (粤)—非经营性—2020-0084 Powered by vancheer